Kaneko Takeaki | Department Of Metabolic Disease Tokyo University Graduate School Of Medicine

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Up-Regulation of Plasminogen Activator Inhibitor-1 in HepG2 Cells by Interleukin (IL)-1 β and IL-6 and Its Attenuation by HMGCoA Reductase Inhibitor
Up-Regulation of Plasminogen Activator Ihibitor-1 Production by Hepatocyte Growth Factar in Liver Cells and Its Potential Clinical Implications for Atherothrombosis
Induction of Plasminogen Activator Inhibitor-1 in Endothelial Cells by Basic Fibroblast Growth Factor and its Modulation by Fibric Acid
Hypofibrinolysis Downregulates Coronary Capillary Network Remodeling in Aged Obese Diabetic Rats : Implications for Increased Myocardial Vulnerability to Ischemia in Diabetes
Proinflammatory Cytokines, lnterleukin-1 and -6, and HMGCoA Reductase Inhibitor Up-regulate Plasminogen Activator Inhibitor-1 Production in a Human Liver Cell Line
Induction of Tissue Factor in Human Endothelial Cells by Basic Fibroblast Growth Factor and its Modulation by Fibric Acid
Novel Polyethylene Glycol Conjugated S-Nitrosylated Hemoglobin Potently Inhibits Platelet Activation and Adhesion to Artificial Surfaces : Therapeutic Implications for Platelet-Rich Thrombus
Critical Role of Rho-Associated Protein Kinase and Genistein Sensitive Pathways for Plasminogen Activator Inhibitor-1 Expression in Adipocytes
Reduced scavenger receptor activity in macrophages from atherosclerosis-resistant strain of mice
Diminished Left Ventricular Function and Coronary Perivascular Fibrosis Associated with Insulin Resistance do not Require Insulin Receptor Substarte-1 Mediated Signaling
Augmented phagocytosis and morphological changes by allograft inflammatory factor-1 in activated macrophages : Implications for transplant vasculopathy and atherosclerosis
Coronary Capillary Remodeling in Non-Insulin-Dependent Diabetic Rats: Amelioration by Inhibition of Angiotensin Converting Enzyme and Its Potential Clinical Implications
IS064 Angiotensin Converting Enzyme (ACE) Inhibitor Attenuates Microvascular Remodeling During the Development of Diabetic Cardiomyopathy in Genetically Obese Mice
PJ-094 Plasminogen Activator Inhibitor-1 Protects Coronary Vascular Wall and Prevents Cardiac Fibrosis in PAI-1-/-, ApoE-/- Mice(PJ016,Molecular Biology/Genetics, Myocardium, Vascular (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The
OJ-115 Hepatocyte Growth Factor and Its Signaling Pathways : Potential Mediators of Increased Plasminogen Activator Inhibitor Type-1 Expression Associated with Insulin Resistance(Thromboembolism/Antithrombotic therapy/Thrombolysis-2 (H) OJ20,Oral Presenta
OE-220 Induction of Adipose PAI-1 Independent of Insulin Receptor Substrate-1 is the Major Determinant of Hypofibrinolysis in Insulin Resistance(Thromboembolism/Antithrombotic therapy/Thrombolysis-1 (H) OE37,Oral Presentation (English),The 70th Anniversar
OE-119 Identification of Insulin Receptor Substrate Family Proteins Mediating PAI-1 Production in Cardiac and Adipose Tissues From IRS-1 Null Mice(Diabetes/Obesity/Metabolic syndrome-1 (H) OE20,Oral Presentation (English),The 70th Anniversary Annual Scien
Induction of Plasminogen Activator Inhibitor-1 Production by Hepatocyte Growth Factor in Liver and Its Potential Clinical Implications for Angiogenesis (Thrombosis/Thrombolysis 1 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Societ
Induction of Adipose PAI-1 by Hyperinsulinemia in Vivo is the Major Determinant of Hypofibrinolysis in Obesity and Doesn't Require IRS-1(Thrombosis/Thrombolysis 2 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
PE-181 CCAAT-Enhancer Binding Protein Delta Mediates the Up-regulation of Plasminogen Activator Inhibitor-1 Induced by lnterleukin-6 and its Attenuation by Mevastatin(Infection/Inflammation/Immunity 2 (H) : PE31)(Poster Session (English))
OJ-209 Hepatocyte Growth Factor Activates PAI-1 Production in Human Liver Cells Through the MEK and Tyrosine Kinase-dependent Signaling Pathways(Blood Coagulation/Fibrinolysis (IHD) : OJ24)(Oral Presentation (Japanese))
OE-318 Maintenance of Cardiac and Adipose PAI-1 Expression Despite the Lack of IRS-1 : a Knockout Mouse Study(Diabetes/Obesity 2 (H) : OE40)(Oral Presentation (English))
Increased Expression of Plasminogen Activator Inhibitor-1 by Mediators of the Acute Phase Response: a Potential Progenitor of Vasculopathy in Hypertensives
Selective Ablation of IRS-1 Decreases Cardiac Contractility without Attenuating PAI-1 Expression or Perivascular Fibrosis
Diminished Fibrinolysis and Thrombosis : Clinical Implications for Accelerated Atherosclerosis
OE-221 Statins Reduce Interleukin (IL)-1 β and IL-6-Induced Plasminogen Activator Inhibitor-1 in Hepatocytes Through C/EBPδ(Thromboembolism/Antithrombotic therapy/Thrombolysis-1 (H) OE37,Oral Presentation (English),The 70th Anniversary Annual Scientific M

もっと見る

スポンサーリンク